Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: Predictive role of bone resorption and formation markers evaluated at baseline

Journal of Urology

Volumn 164, Issue 4, 2000, Pages 1248-1253

  Berruti, Alfredo ^a   Dogliotti, Luigi ^a   Bitossi, Raffaella ^a   Fasolis, Giuseppe ^a   Gorzegno, Gabriella ^a   Bellina, Maurizio ^a   Torta, Mirella ^a   Porpiglia, Francesco ^a   Fontana, Dario ^a   Angeli, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Alkaline phosphatase; Bone; Metastasis; Prostatic neoplasms

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; HEMOGLOBIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE DISEASE; BONE METASTASIS; BONE PAIN; DISEASE ASSOCIATION; FRACTURE; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; SPINAL CORD COMPRESSION; SURVIVAL; VERTEBRA MALFORMATION;

EID: 0033822572     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67149-2     Document Type: Article

References (32)

1. The anatomy and pathways of skeletal metastases
2. Malignant bone resorption: Cellular and biochemical mechanisms
3. Cancer and bone
4. Effects of bone metastases on bone metabolism: Implications for diagnosis, imaging and assessment of response to cancer treatment
5. Biochemical evaluation of bone turnover in cancer patients with bone metastases: Relationship with radiograph appearances and disease extension
6. Generalised increase in bone resorption in carcinoma of the prostate
7. Pamidronate administration improves the secondary hyperparathyroidism due to 'Bone Hunger Syndrome' in a patient with osteoblastic metastases from prostate cancer
8. Progressive osteoporosis during androgen deprivation therapy for prostate cancer
9. Skeletal metastases
10. Skeletal complications of malignancy
11. How is androgen-dependent metastatic prostate cancer best treated?
12. Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serum
13. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen
14. Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology
15. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
16. Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography
17. Total urinary hydroxyproline determined with rapid and simple high-performance liquid chromatography
18. A specific immunoassay for monitoring human bone resorption: Quantification of type I collagen cross-linked N-telopeptides in urine
19. Increased urinary excretion of pyridinium cross-links in cancer patients
20. Urine hydroxyproline excretiona marker of bone metastases in prostatic carcinoma
21. Bone turnover and biochemical markers in malignancy
22. Toxicity and response criteria of the Eastern Cooperative Oncology Group
23. Evaluation of bone disease in breast cancer
24. A computer program for comparing K samples with right-censored data
25. Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: Results from 2 European Organization for Research on Treatment of Cancer trials
26. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center
27. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts
28. Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease
29. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group